Sequence determination and molecular analysis of two strains of bovine parainfluenza virus type 3 that are attenuated for primates

被引:46
作者
Bailly, JE [1 ]
McAuliffe, JM [1 ]
Skiadopoulos, MH [1 ]
Collins, PL [1 ]
Murphy, BR [1 ]
机构
[1] NIAID, NIH, Bethesda, MD 20892 USA
关键词
bovine parainfluenza viruses; human parainfluenza viruses; attenuation determinants; host range; vaccine virus; nucleotide and amino acid sequence alignments;
D O I
10.1023/A:1008130917204
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The Kansas/15626/84 (Ka) and Shipping Fever (SF) strains of bovine parainfluenza virus type 3 (BPIV3) replicate less efficiently than human PIV3 (HPIV3) in the upper and lower respiratory tract of rhesus monkeys, and BPIV3 Ka is also highly attenuated in humans and is in clinical trials as a candidate vaccine against HPIV3. To initiate an investigation of the genetic basis of the observed attenuation phenotype of BPIV3 in primates, the complete genomic sequences of Ka and SF genomes were determined and compared to those of BPIV3 strain 910N and two HPIV3 strains, JS and Wash/47885/57. There is a high degree of identity between the five PIV3 viruses in their 55 nucleotide (nt) leader (83.6%) and 44 nt trailer (93.2%) sequences. The five viruses display amino acid sequence identity ranging from 58.6% for the phosphoprotein to 89.7% for the matrix protein. Interestingly, the majority of amino acid residues found to be variable at a given position in a five-way protein alignment are nonetheless identical within the viruses of either host species (BPIV3 or HPIV3). These host-specific residues might be products of distinct selective pressures on BPIV3 and HPIV3 during evolution in their respective hosts. These host-specific sequences likely include ones which are responsible for the host range differences, such as the efficient growth of BPIV3 in bovines compared to its restricted growth in primates. It should now be possible using the techniques of reverse genetics to import sequences from BPIV3 into HPIV3 and identify those nt or protein sequences which attenuate HPIV3 for primates. This information should be useful in understanding virus-host interactions and in the development of vaccines to protect against HPIV3-induced disease.
引用
收藏
页码:173 / 182
页数:10
相关论文
共 54 条
[1]   COLD ADAPTATION OF PARA-INFLUENZA VIRUS TYPE-3 - INDUCTION OF 3 PHENOTYPIC MARKERS [J].
BELSHE, RB ;
HISSOM, FK .
JOURNAL OF MEDICAL VIROLOGY, 1982, 10 (04) :235-242
[2]   THE CONSERVED N-TERMINAL REGION OF SENDAI VIRUS NUCLEOCAPSID PROTEIN-NP IS REQUIRED FOR NUCLEOCAPSID ASSEMBLY [J].
BUCHHOLZ, CJ ;
SPEHNER, D ;
DRILLIEN, R ;
NEUBERT, WJ ;
HOMANN, HE .
JOURNAL OF VIROLOGY, 1993, 67 (10) :5803-5812
[3]   THE CARBOXY-TERMINAL DOMAIN OF SENDAI VIRUS NUCLEOCAPSID PROTEIN IS INVOLVED IN COMPLEX-FORMATION BETWEEN PHOSPHOPROTEIN AND NUCLEOCAPSID-LIKE PARTICLES [J].
BUCHHOLZ, CJ ;
RETZLER, C ;
HOMANN, HE ;
NEUBERT, WJ .
VIROLOGY, 1994, 204 (02) :770-776
[4]   THE RULE OF 6, A BASIC FEATURE FOR EFFICIENT REPLICATION OF SENDAI VIRUS DEFECTIVE INTERFERING RNA [J].
CALAIN, P ;
ROUX, L .
JOURNAL OF VIROLOGY, 1993, 67 (08) :4822-4830
[5]   EVALUATION OF BOVINE, COLD-ADAPTED HUMAN, AND WILD-TYPE HUMAN PARAINFLUENZA TYPE-3 VIRUSES IN ADULT VOLUNTEERS AND IN CHIMPANZEES [J].
CLEMENTS, ML ;
BELSHE, RB ;
KING, J ;
NEWMAN, F ;
WESTBLOM, TU ;
TIERNEY, EL ;
LONDON, WT ;
MURPHY, BR .
JOURNAL OF CLINICAL MICROBIOLOGY, 1991, 29 (06) :1175-1182
[6]   CONSERVED EPITOPES ON THE HEMAGGLUTININ-NEURAMINIDASE PROTEINS OF HUMAN AND BOVINE PARA-INFLUENZA TYPE-3 VIRUSES - NUCLEOTIDE-SEQUENCE ANALYSIS OF VARIANTS SELECTED WITH MONOCLONAL-ANTIBODIES [J].
COELINGH, KJ ;
WINTER, CC ;
MURPHY, BR ;
RICE, JM ;
KIMBALL, PC ;
OLMSTED, RA ;
COLLINS, PL .
JOURNAL OF VIROLOGY, 1986, 60 (01) :90-96
[7]  
COELINGH KLV, 1988, J INFECT DIS, V157, P655, DOI DOI 10.1093/INFDIS/157.4.655
[8]   NATURALLY-OCCURRING HUMAN PARAINFLUENZA TYPE-3 VIRUSES EXHIBIT DIVERGENCE IN AMINO-ACID-SEQUENCE OF THEIR FUSION PROTEIN NEUTRALIZATION EPITOPES AND CLEAVAGE SITES [J].
COELINGH, KV ;
WINTER, CC .
JOURNAL OF VIROLOGY, 1990, 64 (03) :1329-1334
[9]  
Collins PL, 1996, FIELDS VIROLOGY, V1, P1205
[10]   CURRENT APPROACHES TO THE DEVELOPMENT OF VACCINES AGAINST DISEASE CAUSED BY RESPIRATORY SYNCYTIAL VIRUS (RSV) AND PARAINFLUENZA VIRUS (PIV) - A MEETING REPORT OF THE WHO PROGRAM FOR VACCINE DEVELOPMENT [J].
CROWE, JE .
VACCINE, 1995, 13 (04) :415-421